CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ARMPArmata Pharmaceuticals, Inc.

AMEX · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $3.67 · 2026-09-30
ABOUT
ExchangeAMEX
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$136.46M
CountryUSA
RECENT INSIDER TRADES
  • 2026-07-14 · Birx Deborah (Chief Executive Officer) · OTHER
  • 2026-03-17 · Birx Deborah (Chief Executive Officer) · OTHER
  • 2026-03-17 · Kyme Pierre (Chief Business Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders55
Shares held5,363,194
Value$34.60M
Percent of shares outstanding14.42%
As of quarter end2026-06-30
RECENT NEWS
  • Armata Pharmaceuticals receives two U.S. patent issuances
  • Armata Pharmaceuticals receives $3.7 million from U.S. Department of War
  • Armata to present AP-SA02 data at ISSSI 2026
  • Armata Pharmaceuticals receives FDA breakthrough therapy designation for AP-SA02
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Armata Pharmaceuticals, Inc. (ARMP) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit